Tilray Brands, Inc. (TLRY)
Tilray Brands, Inc. (TLRY) M&A Call Transcript
Tilray Brands, Inc. (TLRY) M&A Call Transcript
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note
Tilray Brands, Inc. (TLRY) reached $7.99 at the closing of the latest trading day, reflecting a +2.04% change compared to its last close.
Don't Even Think About Buying Tilray Stock Until You Read This Warning
Tilray has been expanding beyond marijuana to include hemp products and alcoholic beverages. The company's strategy has led to top-line growth, but it has yet to generate sustainable profits.
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
Tilray Brands' international revenue surge, beverage scale and strong cash position give it an edge over Canopy Growth as cannabis regulation and demand continue to evolve.
Tilray Has Already Done The Hard Part
Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, drives TLRY's growth and margin stability, with Germany and Italy as key markets. Profitability hinges on sustained double-digit international growth, normalized interest and restructuring costs, and EBITDA consistently covering capital needs.
Tilray Brands' Bullish Beverage Strategy: What's Behind the Optimism?
TLRY's Beverage unit faces near-term pressure, but Project 420 savings, brand resets and global expansion underpin its long-term bullish view.
How Tilray Brands Is Acting on Its Vast International Opportunity
TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader global expansion.
What's Next for Tilray Brands After Posting Record Q2 Revenues?
TLRY posts record Q2 revenues of $217.5M as international cannabis and distribution strength outweighs beverage headwinds.
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?
Tilray Brands posts record Q2 revenue of $217.5M, beats sales estimates, reaffirms EBITDA outlook as international cannabis and distribution offset beverage weakness.
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know
TLRY's faces margin pressure in cannabis and beverages, but management sees a beverage turnaround and wellness strength cushioning quarterly results.
